Recently,
I was at my doctor’s office waiting in the exam room. I saw this Pfizer MAINTAIN information on
free medicine assistance for newly unemployed people. So I looked up the media
release to share with you.
It
is so important to stay on your medicine.
If you know of someone who needs free medicine assistance, please pass
this on to them. If I find more programs
such as Pfizer MAINTAIN, I will post them.
© 2008 Pfizer Inc. All rights reserved.
Information about the New Pfizer MAINTAIN™ Program
A Free
Medicines Program for Newly Unemployed Americans
About America
Nearly 46 million Americans lacked health insurance in 2007.1 It is thought that this number has
grown substantially
due to the economic downturn.
• The number of uninsured people is
projected to grow by 1.1 million for each percentage point rise in
unemployment.2
• Unemployment has reached its highest
levels in 25 years.
About the Pfizer MAINTAIN™ Program
The Pfizer MAINTAIN program will help eligible people in financial
need continue to get their Pfizer medicines if they
have recently become unemployed and do not have prescription
coverage. Beneficiaries of the program will get their
Pfizer medicines for free for up to a year or until they become
re-insured (whichever comes first).
• Eligibility: Individuals and their immediate family members are eligible for
this program if:
o They have become unemployed since
January 1, 2009
o They were prescribed and taking a
Pfizer medicine for at least 3 months prior to becoming
unemployed and enrolling in the program
o Lack prescription drug coverage
o Can attest to financial hardship
• Enrollment: Applicants will be asked to complete an easy, one-page form,
attest to financial hardship and
provide proof of unemployment. The program does not require people
to verify income and, as the program
was designed for people who already have a Pfizer prescription, it
will not be necessary to visit the doctor
prior to applying to Pfizer MAINTAIN. Pfizer will process
applications within two to three weeks. People who
think they may qualify should call 1-866-706-2400 or visit www.PfizerHelpfulAnswers.com.
• Benefits: People enrolled in the program will get their Pfizer medicines for
up to one year, or until they
become re-insured (whichever comes first).
• Duration: Pfizer MAINTAIN will become fully operational on July 1, 2009 and
is open for enrollment through
December 31, 2009. The program applies to eligible Americans who
have become unemployed since
January 1, 2009. People who need immediate assistance can contact
the program at 1-866-706-2400 to get
help prior to the program’s official launch.
About Pfizer’s Family of Patient Assistance Programs
Pfizer will incorporate MAINTAIN into Pfizer Helpful Answers®, a
family of patient assistance programs that helps
people without prescription coverage save on many Pfizer
medicines, no matter their age or income. People with
limited income may qualify to get their Pfizer medicines for free.
For information, call 866-706-2400 to speak with a
live Pfizer Helpful Answers operator, in English or Spanish, or
visit www.PfizerHelpfulAnswers.com. People who
call Pfizer Helpful Answers in need of medicines made by other
companies will be referred to the Partnership for
Prescription Assistance, a pharmaceutical industry initiative that
serves to raise awareness of, and boost enrollment
in, more than 475 public and private patient assistance programs.
About Pfizer’s Commitment to Access
Pfizer is committed to helping America
(2004-2008), Pfizer has helped more than 5.1 million patients
receive more than 51.1 million Pfizer prescriptions for
free or at a savings. This equates to nearly $4.8 billion worth of
free medicines and savings.
Pfizer Helpful Answers is a joint program of Pfizer Inc and the
Pfizer Patient Assistance Foundation TM.
1
U.S.
Census Bureau, “Current Population Survey, 2008 Annual Social and
Economic Supplement,” Received August 26, 2008.
2 FamiliesUSA, “Issue Brief: Protecting
Unemployed Workers’ Health Coverage: What States Can Do,” January 2009.
Received May 11, 2009.
Recent Comments